AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.

Latest News

Company updates from every Merlintrader stock hub

Every company update collected in our stock hubs, in one dated list: biotech, space, defense, AI, energy, critical minerals and more. Each headline opens the company’s hub on Merlintrader, and the tag on the right links to the original document, such as the company release, the SEC filing or the clinical trial record. The list updates automatically several times a day; times, when shown, are US Eastern.

DateHeadlineTickerSource
8:45 PM ETMilestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)MISTRelease · GlobeNewswire
6:18 PM ETDataMEDS AI Announces Termination of Second Amended and Restated Letter of IntentMEDSRelease · ACCESS Newswire
5:44 PM ETCuraleaf issues statement regarding alternative proposal for Aurora CannabisACBRelease · PR Newswire
5:03 PM ETCardiol Therapeutics announces at-the-market equity offering program with Jefferies LLCCRDLRelease · PR Newswire
4:45 PM ETAutolus Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)AUTLRelease · GlobeNewswire
4:30 PM ETVanda Pharmaceuticals announces participation at November 2026 investor conferencesVNDARelease · PR Newswire
4:30 PM ETViking Therapeutics to participate at upcoming investor conferencesVKTXRelease · PR Newswire
4:30 PM ETTravere Therapeutics to Participate at Upcoming Investor ConferencesTVTXRelease · Business Wire
First Tracks Biotherapeutics reports third quarter 2026 financial results and provides business updateTRAXRelease · SEC
Oculis Holding AG Unaudited Condensed Consolidated Interim Financial StatementsOCSRelease · SEC
CollPlant Biotechnologies Ltd. calls extraordinary meeting on name change to OptiPhi ComputingCLGNRelease · SEC
4:15 PM ETFirst Tracks Biotherapeutics announces participation in upcoming investor conferencesTRAXRelease · GlobeNewswire
4:15 PM ETCrescent Biopharma announces grants of inducement awardsCBIORelease · GlobeNewswire
4:15 PM ETZentalis Pharmaceuticals to participate in upcoming investor conferencesZNTLRelease · GlobeNewswire
Corcept Therapeutics announces third quarter financial results and provides corporate updateCORTRelease · SEC
Contineum Therapeutics Reports Third-Quarter 2026 Financial ResultsCTNMRelease · SEC
Zevra Reports Third Quarter 2026 Financial Results and Corporate UpdateZVRARelease · SEC
4:05 PM ETBWX Technologies amends $1.25 billion revolving credit facility, extends maturityBWXTFiling · SEC
4:05 PM ETMineralys Therapeutics to Participate in Upcoming Investor ConferencesMLYSRelease · GlobeNewswire
4:05 PM ETOculis reports Q3 2026 financial results and builds momentum toward pipeline catalystsOCSRelease · GlobeNewswire
4:05 PM ETFate Therapeutics reports new employee inducement awards under Nasdaq Listing Rule 5635(c)(4)FATERelease · GlobeNewswire
4:03 PM ET22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026XXIIRelease · GlobeNewswire
Ramaco reports third quarter 2026 net loss of $18.2 millionMETCRelease · SEC
4:01 PM ETAvis Budget Group reports third quarter 2026 resultsCARRelease · GlobeNewswire
4:01 PM ETAquestive Therapeutics reports third quarter 2026 financial results and business updateAQSTRelease · GlobeNewswire
4:01 PM ETUltragenyx Reports Third Quarter 2026 Results, Announces Substantial Expense ReductionsRARERelease · GlobeNewswire
4:01 PM ETSpyre Therapeutics Reports Third Quarter 2026 Financial Results, Provides Corporate UpdateSYRERelease · GlobeNewswire
4:01 PM ETORIC Pharmaceuticals to participate in upcoming investor conferencesORICRelease · GlobeNewswire
4:01 PM ETArdelyx reports third quarter 2026 financial results and provides business updateARDXRelease · GlobeNewswire
4:01 PM ETXenon to present at upcoming investor conferencesXENERelease · GlobeNewswire
4:00 PM ETCytokinetics to participate in November investor conferencesCYTKRelease · GlobeNewswire
4:00 PM ETArrowhead Pharmaceuticals to webcast 2026 fiscal year-end resultsARWRRelease · Business Wire
3:00 PM ETHII successfully completes builder's trials on Harrisburg (LPD 30)HIIRelease · GlobeNewswire
1:38 PM ETOrganigram furnishes news release dated November 3, 2026 via Form 6-KOGIFiling · SEC
10:54 AM ETNovo Nordisk reports share repurchase transactions through 2 November 2026NVOFiling · SEC
Organigram to acquire Aurora and establish a global cannabis leaderACBRelease · SEC
Organigram to acquire Aurora and establish a global cannabis leaderOGIRelease · Business Wire
Starfighters Space to host investor update on Nov. 6FJETRelease · Business Wire
Amylyx Pharmaceuticals to participate in upcoming November investor conferencesAMLXRelease · Business Wire
9:15 AM ETCelebrity Cruises opens bookings for Celebrity Xcite's debut seasonRCLRelease · PR Newswire
9:10 AM ETConversion rate on convertible notes increased after special dividendINDVFiling · SEC
9:02 AM ETSoundHound AI and LG partner to expand commerce opportunities on LG Smart TVsSOUNRelease · GlobeNewswire
9:00 AM ETBriaCell and BriaPro to present preclinical anti-cancer activity at SITC 2026BCTXRelease · GlobeNewswire
9:00 AM ETCapricor Therapeutics to report third quarter 2026 financial results on November 10CAPRRelease · GlobeNewswire
8:31 AM ETLaser Photonics announces name change to LASE Corp.LASERelease · ACCESS Newswire
8:30 AM ETAlnylam to present five-year HELIOS-B data on AMVUTTRA at AHA and ISA 2026ALNYRelease · Business Wire
8:30 AM ETCelcuity to participate in upcoming investor conferencesCELCRelease · GlobeNewswire
Ultragenyx's GTX-102 Angelman study terminated for lack of efficacyRARETrial · ClinicalTrials.gov
Apnimed posts Phase 3 LunAIRo AD109 trial results on ClinicalTrials.govAPMDTrial · ClinicalTrials.gov
8:21 AM ETFDA confirms SeaStar Medical fulfilled QUELIMMUNE post-approval study requirementsICURelease · GlobeNewswire
Momentus secures contract to host OQ Technology 5G payload on Vigoride-9 missionMNTSRelease · Business Wire
Cheniere announces offering of senior notes due 2037LNGRelease · SEC
PALISADE-3 Phase 3 fasedienol trial status updated to completedVTGNTrial · ClinicalTrials.gov
Stoke Therapeutics to present at upcoming investor conferences in NovemberSTOKRelease · Business Wire
Scholar Rock to present at upcoming investor conferencesSRRKRelease · Business Wire
8:00 AM ETHumacyte to highlight coronary bypass research at American Heart Association Scientific Sessions 2026HUMARelease · GlobeNewswire
8:00 AM ETGeron Corporation to participate in the Stifel 2026 Healthcare ConferenceGERNRelease · GlobeNewswire
8:00 AM ET4DMT to participate in upcoming investor conferencesFDMTRelease · GlobeNewswire
8:00 AM ETArdelyx completes enrollment in Phase 3 ACCEL trial of IBSRELA in chronic idiopathic constipationARDXRelease · GlobeNewswire
8:00 AM ETAllogene highlights clinical progress and next-generation CAR T innovation at SITCALLORelease · GlobeNewswire
8:00 AM ETMilestone Pharmaceuticals to announce third quarter 2026 financial results on November 13, 2026MISTRelease · GlobeNewswire
8:00 AM ETIntuitive Machines selected to provide spacecraft platform for FALCON-RADAR missionLUNRRelease · GlobeNewswire
8:00 AM ETIntellia Therapeutics announces upcoming nexiguran ziclumeran (nex-z) medical congress presentationsNTLARelease · GlobeNewswire
8:00 AM ETUroGen Pharma to present at the Guggenheim Securities 3rd Annual Healthcare Innovation ConferenceURGNRelease · GlobeNewswire
7:30 AM ETHelus Pharma to participate in the Guggenheim Healthcare Innovation ConferenceHELPRelease · GlobeNewswire
7:30 AM ETRandall W. Atkins Elected as Chairman of the International Energy Agency's Coal Industry Advisory BoardMETCRelease · PR Newswire
7:30 AM ETBridgeBio to present new acoramidis data on heart failure events in ATTR-CMBBIORelease · GlobeNewswire
7:15 AM ETADC Therapeutics to present at November investor conferencesADCTRelease · PR Newswire
7:15 AM ETDecoy Therapeutics provides third quarter 2026 business updateDCOYRelease · GlobeNewswire
7:05 AM ETREGENXBIO to participate in Stifel 2026 Healthcare ConferenceRGNXRelease · PR Newswire
7:01 AM ETDefinium Therapeutics to participate at upcoming investor conferencesDFTXRelease · Business Wire
7:00 AM ETBlackSky to host investor day on December 2, 2026BKSYRelease · Business Wire
7:00 AM ETTango Therapeutics to participate in Guggenheim's 3rd Annual Healthcare Innovation ConferenceTNGXRelease · GlobeNewswire
7:00 AM ETBlossomHill Therapeutics to present at Guggenheim's 3rd Annual Healthcare Innovations ConferenceBLSMRelease · GlobeNewswire
7:00 AM ETAxsome Therapeutics to participate in upcoming investor conferencesAXSMRelease · GlobeNewswire
7:00 AM ETBeam Therapeutics reports third quarter 2026 financial resultsBEAMRelease · GlobeNewswire
7:00 AM ETMadrigal Pharmaceuticals reports third-quarter 2026 financial results and provides corporate updatesMDGLRelease · GlobeNewswire
7:00 AM ETOpus Genetics to Present at the Guggenheim Annual Healthcare Innovation ConferenceIRDRelease · GlobeNewswire
7:00 AM ETCardiff Oncology to participate in UBS Global Biopharma ConferenceCRDFRelease · GlobeNewswire
7:00 AM ETAnavex names Terrie Kellmeyer, Ph.D., President and Chief Executive OfficerAVXLRelease · GlobeNewswire
7:00 AM ETOruka Therapeutics to participate in multiple upcoming conferencesORKARelease · GlobeNewswire
7:00 AM ETRapport Therapeutics to participate in upcoming investor conferencesRAPPRelease · GlobeNewswire
Compass Pathways announces third quarter 2026 financial results and business highlightsCMPSRelease · Business Wire
6:50 AM ETProtalix BioTherapeutics to announce third quarter 2026 financial results on November 10, 2026PLXRelease · PR Newswire
Karyopharm discloses joint prepackaged Chapter 11 plan disclosure statementKPTIRelease · SEC
6:00 AM ETAmneal reports third quarter 2026 financial resultsAMRXRelease · GlobeNewswire
6:00 AM ETIDEAYA Biosciences reports third quarter 2026 financial results and business updateIDYARelease · PR Newswire
4:00 AM ETCipher, a Prosegur Company, and BIO-key announce technology integration in PortugalBKYIRelease · GlobeNewswire
2:20 AM ETVicore announces the nomination committee for the 2027 Annual General MeetingVCRERelease · ACCESS Newswire
1:00 AM ETHII and Thales successfully demonstrate end-to-end autonomous mine countermeasure missionHIIRelease · GlobeNewswire
6:05 PM ETAgenus to participate in Rodman & Renshaw virtual fireside chatAGENRelease · Business Wire
5:00 PM ETDianthus Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)DNTHRelease · GlobeNewswire
5:00 PM ETZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)ZNTLRelease · GlobeNewswire
4:45 PM ETLeonardo DRS selected by AV for U.S. Army's Enduring-High Energy Laser production programDRSRelease · GlobeNewswire
4:39 PM ETOpus Genetics reports inducement grants under NASDAQ Listing Rule 5635(c)(4)IRDRelease · GlobeNewswire
4:30 PM ETUSA Rare Earth announces date for third quarter 2026 results and conference callUSARRelease · GlobeNewswire
4:30 PM ETiBio to participate in upcoming investor conferencesIBIORelease · GlobeNewswire
4:25 PM ETNew Phase 2 REC-4881 data show deep, durable polyp burden reductions in FAPRXRXRelease · GlobeNewswire
4:15 PM ETINOVIO to report third quarter 2026 financial results on November 10, 2026INORelease · PR Newswire
4:05 PM ETVir Biotechnology to participate in the Jefferies 2026 London Healthcare ConferenceVIRRelease · Business Wire
4:05 PM ETCandel Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)CADLRelease · GlobeNewswire
4:05 PM ETAbivax to participate in upcoming fall investor conferencesABVXRelease · GlobeNewswire
4:05 PM ETSpero Therapeutics to present at investor conferences in NovemberSPRORelease · GlobeNewswire
4:05 PM ETMyriad Genetics to participate in upcoming investor healthcare conferencesMYGNRelease · GlobeNewswire
4:05 PM ETADC Therapeutics Announces New Employee Inducement GrantADCTRelease · PR Newswire
4:05 PM ETRelay Therapeutics to participate in three upcoming investor conferences in NovemberRLAYRelease · GlobeNewswire
4:05 PM ETRecursion appoints Fred Hassan as Chair of the BoardRXRXRelease · GlobeNewswire
4:01 PM ETXenon to Report Q3 2026 Financial Results on November 9, 2026XENERelease · GlobeNewswire
4:01 PM ETDianthus Therapeutics to participate in five investor conferences during NovemberDNTHRelease · GlobeNewswire
4:01 PM ETSyndax announces CFO transition as Aaron A. Ondrey appointed Chief Financial OfficerSNDXRelease · GlobeNewswire
4:01 PM ETINOVIO to participate in upcoming scientific conferencesINORelease · PR Newswire
4:00 PM ETAvalo Therapeutics to participate in upcoming investor conferencesAVTXRelease · GlobeNewswire
1:22 PM ETMission success: Rocket Lab launches 99th Electron missionRKLBRelease · GlobeNewswire
Ocean Power Technologies issues $373,750 12% promissory note to Vanquish FundingOPTTFiling · SEC
Verastem Oncology to participate in upcoming November investor conferencesVSTMRelease · Business Wire
Agenus announces Nature Medicine publication of UNICORN Phase 2 colon cancer trialAGENRelease · Business Wire
Arrowhead Pharmaceuticals to Present Data at American Heart Association Sessions 2026ARWRRelease · Business Wire
Novo Nordisk semaglutide heart failure trial results posted on ClinicalTrials.govNVOTrial · ClinicalTrials.gov
Curtiss-Wright announces new segment leadership team to support next phase of growthCWRelease · Business Wire
Hyatt names Stephen Ho Group President, Asia Pacific; David Udell to become Senior AdvisorHRelease · Business Wire
Hyatt announces pricing of public offering of senior notesHRelease · Business Wire
Crescent Biopharma registers Phase 1/2 CR-002 solid tumor trialCBIOTrial · ClinicalTrials.gov
Amylyx Pharmaceuticals to report third quarter 2026 financial results on November 5, 2026AMLXRelease · Business Wire
TG Therapeutics to host conference call on third quarter 2026 resultsTGTXRelease · Business Wire
Ionis to hold third quarter 2026 financial results webcastIONSRelease · Business Wire
Cytokinetics announces three upcoming presentations at HCMS Scientific SessionsCYTKRelease · GlobeNewswire
Humacyte to announce 2026 third quarter results on November 10, 2026HUMARelease · GlobeNewswire
Compass Pathways and DBSA joint survey reveals lived burden of treatment-resistant depressionCMPSRelease · Business Wire
CRISPR Therapeutics announces appointment of Siva Sakhamuri as Chief Technical OfficerCRSPRelease · GlobeNewswire
Supernus and Indivior complete merger creating a diversified CNS biopharmaceutical leaderINDVRelease · SEC
Three Anavex directors resign from board; committees reconstitutedAVXLFiling · SEC
CollPlant CEO Yehiel Tal steps down; Eran Rotem appointed CEOCLGNFiling · SEC
Avis Budget subsidiaries to redeem $350,000,000 of 5.750% notesCARFiling · SEC
Recursion reports third quarter 2026 results, extends cash runway into 2029RXRXRelease · SEC
Vertex Reports Third Quarter 2026 Financial ResultsVRTXRelease · SEC
Syndax Reports Third Quarter 2026 Financial Results and Provides Business UpdateSNDXRelease · SEC
Palantir reports Q3 2026 revenue growth of 96% Y/Y; raises FY 2026 guidancePLTRRelease · SEC
CRISPR Therapeutics provides business update and reports third quarter 2026 financial resultsCRSPRelease · SEC
BWX Technologies Reports Third Quarter 2026 ResultsBWXTRelease · SEC
Travere Therapeutics Reports Third Quarter 2026 Financial ResultsTVTXRelease · SEC
POET Technologies Names Giovanni Pacelli CFOPOETRelease · SEC
9:45 AM ETRed Cat announces strategic partnership with Sine Engineering for resilient communications and navigationRCATRelease · GlobeNewswire
Karyopharm Therapeutics announces planned merger with Ayrmid Ltd.KPTIRelease · SEC
9:17 AM ETTrulieve receives DEA registrations for state-licensed medical marijuana operationsTRLVRelease · PR Newswire
Marvell to acquire Lumentum, combining complementary electrical and optical technologiesMRVLRelease · SEC
9:00 AM ETCompass Therapeutics to participate in upcoming November investor eventsCMPXRelease · GlobeNewswire
9:00 AM ETAirwaves a wireless carrier sold in August to be part of SpaceX mobile plansSPCXRelease · PR Newswire
8:56 AM ETFDA Provides Clarity to Support Cell and Gene Therapy Development and QualityRegulatory · FDA
Xeris Biopharma welcomes Menassie M. Taddese to Board of DirectorsXERSRelease · SEC
uniQure announces FDA acceptance and priority review of BLA for ifezuntirgene inilparvovecQURERelease · SEC

Load more news

Browse every company we cover in the Stock Hubs index, follow upcoming FDA and clinical dates in the Biotech Catalyst Calendar and download full reports from the Research Library.

Disclaimer. This page is published by Merlintrader for educational and informational purposes only. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security. Headlines summarize company announcements, regulatory filings and public records; readers should verify every item against the original document linked on each line before acting on it.

Small and mid-cap stocks, and biotech companies in particular, can move sharply on clinical, regulatory and financing news, and investors can lose all of the capital invested. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate. Merlintrader may hold positions in securities mentioned, and some links on this site are affiliate or referral links. Full legal information is available on the disclaimer and terms of use and privacy pages.